aminoimidazole carboxamide has been researched along with Dysplastic Nevus Syndrome, Hereditary in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (100.00) | 2.80 |
Authors | Studies |
---|---|
Abbe, P; Amdouni, H; Auberger, P; Ben-Sahra, I; Benhida, R; Beranger, GE; Cluzeau, T; Driowya, M; Dubreuil, P; Furstoss, N; Gutierrez, VS; Jacquel, A; Jaune, E; Luciano, F; Martin, AR; O'Hara, BP; Passeron, T; Regazzetti, C; Robert, G; Rocchi, S; Tekaya, N; Tulic, MK; Zerhouni, M | 1 |
1 other study(ies) available for aminoimidazole carboxamide and Dysplastic Nevus Syndrome, Hereditary
Article | Year |
---|---|
Dual Covalent Inhibition of PKM and IMPDH Targets Metabolism in Cutaneous Metastatic Melanoma.
Topics: Aged; Aminoimidazole Carboxamide; Animals; Carrier Proteins; Cell Line, Tumor; Female; HEK293 Cells; Humans; IMP Dehydrogenase; Melanoma; Melanoma, Cutaneous Malignant; Membrane Proteins; Mice; Mice, Nude; Random Allocation; Ribonucleotides; Skin Neoplasms; Thyroid Hormone-Binding Proteins; Thyroid Hormones; Xenograft Model Antitumor Assays | 2021 |